2025 Cultivation Research and Development Treatment 
Cannabis Law Report
JUNE 28, 2021
Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.
Cannabis Law Report
NOVEMBER 28, 2021
Medical cannabis business Equinox International is planning to list on the London Stock Exchange to raise cash for a ‘state-of-the-art’ cultivation, extraction and production facility on a Home Office-approved 20-acre UK site. UK medical cannabis market to have addressable market of £7.5bn by 2028 .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
JANUARY 18, 2023
Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. The brothers boast years of experience in hemp cultivation. After exhausting alternative treatment options, her mother Paige desperately started looking for a way to improve Charlotte’s quality of life.
Cannabis Law Report
JANUARY 12, 2020
But in Thailand change is afoot, as authorities seek to develop a homegrown medical marijuana industry. It has approved use of cannabis extracts for treatment of a range of illnesses and conditions, including cancer, epilepsy, Alzheimer’s, Parkinson’s disease and anxiety. billion ($96 billion) by the end of 2025.
Veriheal
JUNE 21, 2023
Rhode Island has joined the list of states that have eased the restrictions on using and cultivating psilocybin mushrooms. The legislation permits Rhode Islanders to possess 1 ounce of psilocybin and cultivate magic mushrooms for personal use. Speaking on the recent developments, Rep. The bill was introduced by Rep.
Cannabis Law Report
JULY 15, 2022
The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. “We cultivate, we produce, we manufacture, we bottle and then we distribute onsite, which I think for accountability is very important.
Cannabis Law Report
JUNE 8, 2021
And all thanks to the latest medical research. If earlier cannabis was a taboo subject due to its psychedelic properties, then with the development of technologies that allow the extraction of pure cannabidiol, the situation has changed radically. The development of new varieties and genetic research. In 2018, the U.S.
Expert insights. Personalized for you.
105 
Let's personalize your content